Neumora Therapeutics, Inc. - NMRA

Latest data: 4/4/2025 10:40:59 PM
EDGAR CIK 0001885522

Buy Breakdown

Total $0

Sell Breakdown

Total $1,141,628

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
02/18/2025
10b5-1
02/20/2025
Chief Strategy Officer
Officer
Sell
-8,565 @ $1.68
($14,347.23)
88,935 (-8.78%) Direct
02/18/2025
10b5-1
02/20/2025
Title: Chief Executive Officer and Chairman of the
CEO Director
Sell
-13,871 @ $1.69
($23,468.34)
7,405,004 (-0.19%) Direct
02/18/2025
10b5-1
02/20/2025
Head of R&D
Officer
Sell
-5,614 @ $1.67
($9,383.24)
309,092 (-1.78%) Direct
02/18/2025
10b5-1
02/20/2025
Title: Chief Financial Officer & Principal Account
CFO
Sell
-1,978 @ $1.69
($3,350.53)
22,470 (-8.09%) Direct
02/18/2025
10b5-1
02/20/2025
President
Officer
Sell
-8,048 @ $1.67
($13,477.18)
76,952 (-9.47%) Direct
10/10/2024
10b5-1
10/11/2024
Head of R&D
Officer
Sell
-8,260 @ $15.09
($124,602.93)
314,706 (-2.56%) Direct
10/09/2024
10b5-1
10/11/2024
Head of R&D
Officer
Sell
-5,563 @ $15.01
($83,507.31)
322,966 (-1.69%) Direct
09/18/2024
10b5-1
09/19/2024
Head of R&D
Officer
Sell
-10,676 @ $12.09
($129,090.99)
328,529 (-3.15%) Direct
09/17/2024
10b5-1
09/19/2024
Head of R&D
Officer
Sell
-30,788 @ $11.81
($363,735.59)
339,205 (-8.32%) Direct
09/12/2024
10b5-1
09/16/2024
Head of R&D
Officer
Sell
-32,948 @ $11.43
($376,664.83)
369,993 (-8.18%) Direct